Step Pharma Alternatives & Competitors
12 companies similar to Step Pharma — Developing selective inhibitors of CTPS1 for patients with cancer and auto-immun...
Companies similar to Step Pharma
Odyssey Therapeutics
Building a machine learning-based platform to develop novel therapeutics focusing on cance...
ROME Therapeutics
Harnessing the power of the repeatome to develop a new class of therapies for cancer and a...
Boston, United States
Kanaph Therapeutics
We are the leader of next generation immuno-oncology and autoimmune diseases.
Seoul, Korea South
Track all Step Pharma competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
OncXerna Therapeutics
Advancing a new paradigm of precision oncology with a RNA-based approach to match patients...
Waltham, United States
Lisata Therapeutics, Inc.
Targeted Therapy Delivered
United States
Bolt Biotherapeutics, Inc.
Plans to develop a novel format for T-cell mediated anti-tumour therapy
Redwood City, United Stat...
BiPar Sciences
Innovative therapies harnessing the power of PARP inhibitors to combat advanced cancers
Captor Therapeutics SA
Captor Therapeutics aims to treat cancer, infections, and diseases by targeting the diffic...
Poland
Sitryx
Harnessing the power of cell metabolism to develop groundbreaking disease-modifying therap...
Oxford, United Kingdom
Semafore Pharmaceuticals
Pioneering the future of cancer treatment with innovative PI3K inhibitors.
Nirogy Therapeutics
Pioneering innovative small molecules to disrupt metabolic and immune pathways, advancing...
About Step Pharma
Step Pharma is a France-based biotechnology and pharmaceutical company, founded in 2014, that specializes in developing selective inhibitors of CTPS1 (cytidine triphosphate synthase 1) for the treatment of cancer and autoimmune diseases. The company's lead program, dencatistat (STP938), is a potent, selective, oral inh...
Development of targeted oncology therapies
Patients with various cancer types
CTPS1 Inhibitors, Oncology, Autoimmune Diseases, Biopharmaceuticals, Clinical Development, Cancer Therapy, Biomarker Selection, Genetic Immunodeficiencies Research, Synthetic Lethality, Biotech Research, Biomarker-driven Therapy, Drug Discovery, Tumor Agnostic Approach, Immunotherapy, Venture-backed Biotech
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Step Pharma and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Step Pharma on 7 Jun 2025. The 12 companies listed here were last checked between 26 Jul 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
